'Ozempic Face' Is Real. Here's What Causes It and How to Minimize It.

"Ozempic face" is a real thing — and if you've noticed it in yourself or someone you know, you're seeing the visible expression of what happens when facial fat disappears faster than the overlying skin can adapt.

But let's be precise about what it actually is, because the framing matters.

What Ozempic Face Actually Is

"Ozempic face" is not a side effect of semaglutide. It's a side effect of rapid, significant weight loss — of which semaglutide is currently the most effective cause.

When you lose substantial weight quickly, you lose fat from throughout your body, including your face. Facial fat has historically been underappreciated in its role in youthful appearance. The cheeks, temples, under-eye hollows, jaw, and neck all have fat compartments that contribute to fullness, structural support, and the smooth contours associated with youth.

As those fat compartments deflate, you're left with: - Hollow, sunken cheeks - More prominent nasolabial folds ("smile lines") - Under-eye hollowing and darker circles - Jowling along the jawline - Looser, crepier skin overall - A general gauntness that reads as "older"

The face follows the same physics as the rest of the body: volume loss + skin that doesn't fully snap back = visible aging.

The name "Ozempic face" is mostly media-driven. Bariatric surgeons have seen this for decades. Oncologists see it in patients losing weight during cancer treatment. Any rapid, significant weight loss can produce it. GLP-1 medications are just producing it at unprecedented scale, so suddenly it's in Vogue.

Why Some People Are Affected More Than Others

Age is the biggest predictor. Younger skin has more elasticity and collagen, meaning it adapts better to volume changes. A 32-year-old who loses 30 lbs will likely have a different facial outcome than a 55-year-old losing the same amount.

Rate of weight loss matters. Slow, gradual weight loss gives the skin more time to adapt. GLP-1's rapid initial weight loss (often 1-2 lbs/week in early months) accelerates the visible impact.

Baseline facial volume. People with naturally fuller, rounder faces have more "buffer" before hollowing becomes visible. Those who were already on the slimmer end facially have less to lose before the effect becomes noticeable.

Amount of total weight lost. Patients losing 10% of body weight have very different facial outcomes from those losing 20-25%.

Prevention and Mitigation

Control the rate of weight loss. You don't need to maximize GLP-1 effectiveness at the expense of your appearance. Working with your physician to maintain a moderate caloric deficit (rather than near-starvation levels) produces more sustainable weight loss and gives skin more time to adapt. Target 0.5-1% of body weight per week rather than pushing for 1.5-2%.

Protein and collagen. Adequate protein intake supports skin integrity. Collagen peptide supplementation (10-20g/day) has emerging evidence for improving skin elasticity. These aren't miracle interventions, but they matter at the margins.

Resistance training. Maintaining muscle everywhere, including the face (via neck and facial muscles), contributes to structural support. More importantly, resistance training preserves overall lean mass — which reduces the proportion of weight loss coming from places you don't want.

Hydration. Dehydrated skin looks worse in all the same ways as volume-depleted skin. GLP-1 patients who eat less also often drink less; conscious water intake helps.

Treatment Options If It's Already Happened

If you're already experiencing facial changes:

Dermal fillers (hyaluronic acid — Juvederm, Restylane) directly restore volume in the cheeks, temples, and under-eye area. Effects are immediate, lasting 12-18 months. This is currently the most common cosmetic intervention for GLP-1-related facial changes, and cosmetic physicians report a significant uptick in demand.

Biostimulators (Sculptra, Radiesse) stimulate your own collagen production over time rather than immediately adding volume. Results are more gradual but often more natural-looking; effects last 2+ years.

Radiofrequency and ultrasound treatments (Thermage, Ultherapy) tighten skin without adding volume — helpful for laxity along the jawline but less effective for volume deficit.

Waiting — some patients find their face adjusts somewhat over 12-18 months as skin adapts and minor volume redistributes. Not a guaranteed outcome, but many patients stabilize.

The Bigger Picture

The framing of "Ozempic face" as a disaster or dealbreaker is mostly aesthetic media clickbait. The metabolic improvements from significant weight loss — reduced cardiovascular risk, better insulin sensitivity, reduced inflammation, improved joint health — are real and substantial.

For most patients, the right approach is: prevent it where possible through controlled weight loss rate and nutrition, accept that some change is normal and expected with significant weight loss regardless of method, and treat it if needed with tools that are widely available and effective.

Your [Marrow](/semaglutide) physician can help you dial in a weight loss rate that optimizes both your metabolic goals and your aesthetic outcomes. This isn't just about looking good — sustainable weight loss at a reasonable rate produces better long-term results than maximally aggressive caloric restriction.